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Abstract 12	
Advances in metabolic engineering have led to the synthesis of a wide variety of valuable 13	
chemicals in microorganisms. The key to commercializing these processes is the improvement of 14	
titer, productivity, yield, and robustness. Traditional approaches to enhancing production uses 15	
the “push-pull-block” strategy that modulates enzyme expression under static control. However, 16	
strains are often optimized for specific laboratory set-up and are sensitive to environmental 17	
fluctuations. Exposure to sub-optimal growth conditions during large-scale fermentation often 18	
reduces their production capacity. Moreover, static control of engineered pathways may 19	
imbalance cofactors or cause the accumulation of toxic intermediates, which imposes burden on 20	
the host and results in decreased production. To overcome these problems, the last decade has 21	
witnessed the emergence of a new technology that uses synthetic regulation to control 22	
heterologous pathways dynamically, in ways akin to regulatory networks found in nature. Here 23	
we review natural metabolic control strategies and recent developments in how they inspire the 24	
engineering of dynamically regulated pathways. We further discuss the challenges of designing 25	
and engineering dynamic control and highlight how model-based design can provide a powerful 26	
formalism to engineer dynamic control circuits, which together with the tools of synthetic 27	
biology, can work to enhance microbial production. 28	
 29	
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§ 1. Introduction 33	
Microbial production of valuable chemicals provides an attractive alternative to petroleum-based 34	
synthesis routes. A wide variety of chemicals such as biofuels, pharmaceuticals, and 35	
nutraceuticals have been successfully produced in microbial hosts by assembling and optimizing 36	
metabolic pathways [71,47,48]. Typically, the expression of pathway enzymes is either 37	
constitutive or under the control of inducible promoters that are tuned to balance the pathway 38	
flux to maximize titers, productivities, and yields. Static overexpression of enzymes can impose 39	
a load onto the cell by competing for native resources from metabolism and draining resources 40	
such as ribosomes, ATPs and chaperones [23]. The extra load to the host cell also makes it 41	
challenging to dynamically balance resource allocation between cell growth and the engineered 42	
pathway. In addition, the obtained strains are often optimized under certain laboratory conditions 43	
and are not as robust in large bioreactors, where environmental fluctuations (e.g., nutrient 44	
concentration, temperature, dissolved oxygen, etc.) can subject cells to suboptimal conditions 45	
and lead to decreased production. Deviation from the optimal condition may divert carbon to 46	
byproducts or lead to the accumulation of toxic intermediates that attenuate cell growth [42]. 47	
Furthermore, engineered strains often suffer from stability issues where genetic mutations may 48	
arise during fermentation that deactivate the pathway activity. By comparison, natural cells 49	
maintain robust growth and withstand environmental fluctuations by dynamically adjusting 50	
cellular metabolism through complex regulatory networks. These regulatory networks govern the 51	
distribution of cellular resources and sustain homeostasis in fluctuating environments. 52	
The study of how natural regulatory networks enable cells to grow robustly has been a 53	
focus in systems biology. Diverse regulation mechanisms have been identified to dynamically 54	
control metabolism in response to varying environmental conditions and intracellular metabolic 55	
status [29,39,30,16]. These mechanisms sense environmental signals such as nutrient 56	
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concentration, pH, and light, as well as intracellular metabolite concentrations and cell density. 57	
The sensed signals are then coupled to transcriptional, translational or post-translational 58	
processes to control protein expression or activities for efficient carbon usage. Taking the 59	
concept of dynamic regulation, synthetic biologists have designed genetic circuits to dynamically 60	
regulate engineered pathways for optimal biochemical production [73,24,18,76,37,22,70,68]. 61	
In this review we discuss dynamic control strategies found in nature and how they inspire 62	
engineering efforts to increase bioproduction, with a particular focus on the design of control 63	
architectures. We further discuss some of the key challenges to designing dynamic control for 64	
enhancing biochemical production and highlight the utility of mathematical models to help 65	
address these. We conclude with an outlook that integrating design principles learned from 66	
natural control systems and model-based design into the metabolic engineering workflow can 67	
facilitate the design of dynamic metabolic control, towards the development of robust and 68	
efficient microbial cell factories. 69	
  70	
§ 2. Natural strategies for dynamic control of metabolism 71	
Dynamic regulation of metabolic pathways is ubiquitous in nature. Spanning from simple 72	
microbes to multicellular animals, all forms of life depend on complex regulatory networks to 73	
coordinate metabolism to maintain cellular activity and adapt to environmental changes. To 74	
achieve this, cells use a variety of strategies that involve the interplay between DNAs, RNAs, 75	
regulatory proteins, enzymes and metabolites. Transcriptional regulation represents a significant 76	
level of control that is responsive to a wide variety of molecules and exhibits versatile regulatory 77	
architectures. In Escherichia coli, 577 interactions have been identified between transcription 78	
factors and their regulated operons [55], and this number is still growing. These complex 79	
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interactions are made up of network motifs with different architectures that give rise to different 80	
functions [1].   81	
One major function of dynamic regulation is to allocate resources efficiently. This is 82	
mostly achieved by transcriptional control to avoid high cost of protein synthesis. At the 83	
transcriptional level, the expression of enzymes is often controlled by transcription factors that 84	
can sense either an intermediate or product of a pathway, generating different regulation 85	
architectures. For example, in the lysine biosynthesis pathway in Saccharomyces cerevisiae, the 86	
transcription factor Lys14 is activated by an intermediate alpha aminoadipate 6-semialdehyde 87	
(αAAS), which activates all the seven genes in the pathway. Similarly, enzymes in the arginine 88	
biosynthesis pathway of E. coli are repressed by ArgR, which is in turn activated by the end 89	
product arginine. Experimental analyses and cost-benefit models for enzyme expression have 90	
uncovered links between regulatory architecture and the timing of gene expression in unbranched 91	
pathways [44,15,72,17], revealing unique patterns of timing and promoter activity for efficient 92	
enzyme expression. 93	
In addition to the transcriptional level, many cellular activities are modulated at the 94	
translational and post-translational levels, and oftentimes interplay among them. Translational 95	
regulation, usually through controlling translation initiation rate or mRNA stability, only respond 96	
to a small number of metabolites due to the limited chemical diversity of nucleic acids. Post 97	
translational regulation is abundant in metabolic pathways and controls enzyme activities in 98	
response to environmental stimuli or metabolite concentrations. For example, enzymes in E. coli 99	
central metabolism are heavily regulated at the post-translational level to tightly maintain 100	
constant metabolic flux under small environmental perturbations [50]. In addition, product 101	
allosteric inhibition of the first enzyme in metabolic pathways is commonly observed to rapidly 102	
turn down the metabolic flux through the pathway, allowing for immediate saving on carbon 103	
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usage. By comparison, transcriptional or translational regulation, though responding at a slower 104	
time scale due to slow protein synthesis and dilution, can drastically shift the distribution of 105	
metabolic flux and enable cells to save resources in the long run. Among different levels of 106	
regulation, transcriptional regulation offers a variety of traits desirable for engineering 107	
applications, including versatility in regulation architecture, chemical diversity of the sensed 108	
molecules, and tunability of the regulatory parameters. Indeed, transcriptional regulation is the 109	
most widely used control in metabolic engineering. Overall, understanding natural regulatory 110	
mechanisms provides us a wide variety of tools and design principles to develop synthetic 111	
dynamic control, which can be applied in metabolic engineering [36].  112	
 113	
§ 3. Engineered strategies for dynamic control of metabolism 114	
A synthetic dynamic control circuit typically consists of a biosensor and a genetic 115	
controller. The application of biosensors [75,39,35,74] and genetic control circuits [58,10] have 116	
been extensively reviewed. A variety of signals can be sensed, such as intracellular metabolites, 117	
quorum signal molecules (AHLs), exogenous stimuli (inducers and lights), environmental signals 118	
(pH, oxygen, and temperature), and molecules that reflect cellular growth status (exponential 119	
growth v.s. stationary growth, etc.). These signals can be used to repress or activate enzyme 120	
expression and thus regulate flux of a pathway. One primary design objective for dynamic 121	
control of metabolic flux is to balance the growth of the cell and production of the target 122	
molecule. Next, we discuss different types of design strategies from input signals to output 123	
regulations that attempt to address this objective. 124	
The basic method to dynamically regulate the flux distribution is adding exogenous 125	
inducers or nutrients at a time point during fermentation (Fig. 1a). Xie et al. constructed a 126	
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glucose-dependent regulatory system in S. cerevisiae to control the flux from branch point 127	
farnesyl diphosphate (FPP) to ergosterol biosynthesis (an essential component in yeast 128	
membrane) or to the carotenoid pathway [69]. Squalene synthase (erg9), the first gene from FPP 129	
to ergosterol pathway, was placed under the HXT1 promoter, which was induced at high glucose 130	
concentration, while the carotenoid pathway was controlled by glucose-repressible GAL 131	
promoters so that the production pathway was turned on after glucose was partially replaced by 132	
glycerol as an alternative carbon source. Dynamic regulation by exogenous inducers is 133	
straightforward and effective, but requires addition of inexpensive and environmentally-friendly 134	
inducers. These limitations can be overcome by introducing feedback control of enzyme 135	
expression to respond to signals produced by the cell itself. 136	
An example of autonomous control is that on growth flux through negative feedback by a 137	
quorum sensing (QS) system (Fig. 1b). Soma and Hanai employed a QS system to autonomously 138	
redirect acetyl-CoA from the TCA cycle to the isopropanol pathway at a given cell density [60]. 139	
In a recent application, QS was used to downregulate phosphofructokinase-1 (pfk-1) in the upper 140	
glycolysis pathway [24]. Lower pfk-1 activity channeled more carbon flux from the 141	
interconverting branch points G6P and F6P to the glucaric acid pathway, thus turning on product 142	
synthesis while inhibiting cell growth.  143	
One key function of dynamic control in a biosynthetic pathway is to avoid accumulation 144	
of toxic intermediates or overexpression of toxic enzymes. Inhibiting an upstream pathway that 145	
generates the toxic intermediate and activating a downstream pathway that converts it are 146	
common control strategies (Fig. 1c). One of the pioneering works in dynamic pathway regulation 147	
was demonstrated for biodiesel production from free fatty acids [73]. In the pathway, 148	
accumulation of two intermediates ethanol and acyl-CoA is harmful to cell growth. The authors 149	
developed a dynamic regulatory system to activate ethanol production and the conversion of 150	
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ethanol and acyl-CoAs to final products only when fatty acyl-CoAs are sufficient. In another 151	
example, promoters responsive to FPP (toxic to cell) accumulation were used to repress the 152	
mevalonate pathway that produces FPP and to activate amorphadiene synthase that consumes 153	
FPP. Such regulatory topology dynamically stabilized the FPP concentration below its toxic 154	
level, while increasing amorphadiene production [18]. Similar control topologies can be 155	
constructed using transcription-factor-based sensors as demonstrated in the fatty acid pathway to 156	
optimize cellular malonyl-CoA pool [70]. In addition, synthetic inverters can be used to switch 157	
regulation between repression and activation, achieving a desired control topology [37].  158	
Dynamic regulation can also be implemented by sensing signals that reflect the growth 159	
status of the host and using them to control production. In one of the first examples of dynamic 160	
regulation, acetyl phosphate served as the signal for excess glycolytic flux to regulate the rate-161	
limiting enzymes in lycopene pathway [22] (Fig. 1d). Recently, a biosynthetic pathway was 162	
controlled by a two-layered circuit, which acted as an AND gate that senses both the cellular 163	
growth status and the pathway precursor availability [38]. The first enzymatic step was not 164	
turned on until stationary phase and downstream steps were activated by the intermediate from 165	
the first step (Fig. 1e), which reduces burden from the engineered metabolic pathway. Synthetic 166	
control can also be designed to sense production flux and regulate growth (Fig. 1f). Xiao et al. 167	
described a strategy that uses metabolite product to activate cell growth via expression of an 168	
antibiotic pump, TetA [68]. This ensured that high producing cells would tolerate the antibiotic 169	
treatment, and thus facilitated the selection of high producing phenotypes at the population level. 170	
Without selection, a wide variation in biosynthetic performance was observed in the whole 171	
population. With selection, only the high-performing cells could survive, thus increasing total 172	
production.  173	
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Despite a growing number of success stories, engineering dynamic control remains 174	
extremely challenging. Current implementations require multiple iterations between construction 175	
of part libraries, testing of different control architectures, and characterization of system 176	
performance. This lengthy design cycle is the result of multiple challenges that need to be 177	
addressed if the field is to move towards precision engineering of metabolism.  178	
 179	
§ 4. Challenges for dynamic control and benefits of model-based design. 180	
Current challenges for dynamic control include the construction and tuning of genetic 181	
parts, the assembly of parts into functional circuits, the interplay between circuit and host, and 182	
the control of population diversity (Fig. 2). Some of these challenges are particularly relevant for 183	
the success of dynamic control in industrial applications. For example, in large fermenters the 184	
level of intracellular metabolites and the environmental conditions can vary. Because biosensors 185	
are typically designed to function in model organisms under controlled laboratory conditions, 186	
their sensing ability may be impaired in industrial hosts with highly variable conditions. Control 187	
circuits also need to function robustly during long periods of fermentation, which in turn requires 188	
a good understanding of the host-circuit interactions that drive the allocation of resources within 189	
the host. Lastly, in large bioreactors there are often increased cell-to-cell variations [68], and the 190	
challenge is how to control the product distribution to shift the population to achieve higher 191	
percentage of high-producers. 192	
Mathematical modelling is an ideal framework to integrate different design layers and 193	
explore the design space in a rational manner. Next, we discuss some of the key challenges ahead 194	
and outline how modelling can help overcome them.  195	
 196	
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§ 4.1. Construction of tunable parts 197	
Metabolite biosensors are a key component of dynamic metabolic control. Their function 198	
is to control the expression of pathway enzymes in response to metabolic signals such as the 199	
concentrations of metabolic intermediates or other physicochemical cues. Growth conditions 200	
may shift metabolite concentrations to ranges that fall beyond the detection range of biosensors, 201	
thus impairing dynamic control and resulting in a static system unable to regulate enzyme 202	
expression. Tunability of biosensors is therefore essential for dynamic control systems to 203	
appropriately function in industrial conditions. Biosensors must respond with the appropriate 204	
sensitivity and actuate the response at the right signal threshold, according to the growth 205	
conditions. Biosensor function can be captured in the dose-response curve, which relates the 206	
concentration of the sensed metabolite to the enzyme expression (Fig. 2), and its shape can be 207	
modified through experimentally tunable parameters such as the metabolite binding affinity or 208	
the sequence of target promoters [40]. Some of the successful implementations of dynamic 209	
control have demonstrated that tuning the biosensor dose-response curve can affect performance 210	
significantly and increase production [37,70,68]. The question of how to design dynamic control 211	
is thus critical for developing production strains, especially for application in industrial settings. 212	
Much work has focused on developing new biosensors, but the precise calibration of their dose-213	
response curve remains poorly understood [3] and leads to lengthy iterations between biosensor 214	
construction and characterization. 215	
Common biosensors in dynamic control are transcriptional riboswitches [7] and 216	
transcription factors [75]. Progress in RNA engineering has led to a growing number of 217	
riboswitches that respond to specific metabolites [66,26]. Studies have shown that RNA 218	
sequences shape the sensitivity and threshold of riboswitch dose-response curves [52,5], yet the 219	
precise tuning of riboswitch function remains a significant challenge. Computational methods 220	
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have proven powerful for the design of RNA devices [13] and mathematical modelling has 221	
revealed insights on the tunability of the riboswitch function in terms of biophysical parameters 222	
[6]. Integration of sequence design algorithms with mathematical models may facilitate the 223	
discovery of new metabolite-responsive riboswitches, and thus expand the repertoire of pathways 224	
in which dynamic control can be used [7]. 225	
In the case of transcription factors, dose-response curves can be tuned with promoter 226	
engineering [40] or protein engineering to modify metabolite binding kinetics [63]. There are 227	
many natural transcription factors that respond to specific metabolites in their native host, which 228	
can be repurposed as biosensors in a production host of interest. Detailed biophysical models 229	
have revealed relations between sequence-dependent promoter binding affinities and protein 230	
expression [9]. Moreover, mathematical models have uncovered fundamental design constraints 231	
of dose-response curves, and revealed strategies for orthogonal control of biosensor dynamic 232	
range and threshold [40]. 233	
§ 4.2. Assembling parts to design control circuits 234	
To increase production, dynamic control circuits must achieve multiple design objectives 235	
simultaneously [46]. The goal is to construct control circuits that adapt pathway activity to 236	
varying bioreactor conditions, ensuring efficient expression of enzymes, minimizing the impact 237	
of pathway bottlenecks or accumulation of toxic intermediates, and ultimately maximize yield, 238	
titer or productivity at industrial scales. Achieving all these objectives demands the availability 239	
of a wide repertoire of control circuit architectures, but in reality architectures are severely 240	
constrained because well-characterized metabolite biosensors exist only for few relevant 241	
compounds [75]. Key questions for architecture design are which pathway metabolite should be 242	
sensed, and which enzymatic steps to implement dynamic control. Mathematical modelling can 243	
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be a powerful tool to explore such design space and assess performance of architectures that 244	
would otherwise be infeasible or too costly to test experimentally. 245	
Unlike in static control, where genome-scale models can be used for strain design 246	
[11,57], model-based approaches for dynamic control are still in early stages. Mathematical 247	
models have revealed design principles to improve biofuel production through control of efflux 248	
pumps [21] and have provided conditions on the parameter design space to avoid accumulation 249	
of toxic intermediates [46]. Genome-scale models have been employed to determine which 250	
enzymes to control, which when coupled with dynamic modelling showed higher production as 251	
compared to static control [2]. A particularly promising use for modelling is the exploration of 252	
circuit architectures. Models have been used to search for architectures that efficiently trade-off 253	
production flux against toxicity effects by metabolic intermediates [61], to explore circuit 254	
architectures that function robustly in the face of environmental or genetic perturbations [25], or 255	
to discover new useful architectures, such as a bistable metabolic switch that filters out 256	
fluctuations in nutrient availability [43]. 257	
Control engineering has been tremendously successful in designing regulation systems 258	
for diverse disciplines such as aerospace, bioprocessing, and information technologies [4]. 259	
Principles from control engineering have gained ground in synthetic biology [19] and optimal 260	
control ideas have revealed design principles in natural metabolic systems [65,72], but their 261	
broader application to dynamic pathway control remains less explored. A potential area for 262	
future development is the use of mathematical optimization for circuit design [53] coupled with 263	
detailed kinetic models of metabolism [32,49,41,14,27]. Optimization of control architectures 264	
also faces significant computational challenges, as the sheer number of circuit designs and 265	
tunable parameters may lead to optimization problems that cannot be solved in feasible time. 266	
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Trade-offs between circuit size and computation time needs to be considered and the 267	
development of scalable optimization methods poses multiple opportunities for further research. 268	
§ 4.3. Host-circuit interactions 269	
As metabolic pathways and control circuits become larger and more complex, their 270	
footprint on their host can become a major limiting factor on function. Engineered systems draw 271	
resources from the host, which can disrupt homeostasis and cause growth defects that lead to 272	
poor or even altered functionality [62,12]. A key source for host-circuit interactions is the 273	
competition for cellular resources such as ribosomes, RNA polymerases, and amino acid pools 274	
[8]. This competition affects cell growth and ultimately may result in impaired circuit function, 275	
leading to suboptimal production that is economically impractical at industrial scale. 276	
Mathematical models can give a systems-level understanding of the relationship between 277	
circuit function and the physiology of the host where they reside. To this end, Weiße and 278	
colleagues developed a mechanistic model for bacterial growth, based on a coarse-grained 279	
partition of the proteome and its interaction through metabolism, transcription and translation 280	
[67]. The model predicts growth defects caused by gene circuits and provides a quantitative 281	
platform to assess the impact of growth defects on circuit function. A recent extension to this 282	
work includes more detailed mechanisms of the different host-circuit crosstalks and proved 283	
useful for circuit design [34]. Models for host-circuit interactions do not yet allow the inclusion 284	
of dynamic pathway control, but the use of dynamic control to manage host load and increase 285	
production is promising, especially in light of recent evidence showing that feedback control can 286	
mitigate the impact of resource coupling [56].  287	
§ 4.4. Control of population heterogeneity 288	
14	
Phenotypic heterogeneity is ubiquitous in cellular populations. In microbes, heterogeneity 289	
has been extensively studied as a product of stochasticity in gene expression and the resulting 290	
variation in protein levels [51], and recent work has focused on variability on metabolic 291	
phenotypes and growth [59,31,28]. Though phenotypic variability in natural systems can serve as 292	
a population survival strategy, variability amongst strains engineered for production can lead to 293	
suboptimal performance. Phenotypic variability may also result from fluctuations in growth 294	
conditions, and the inhomogeneities in growth media can be further exaggerated when scaling-up 295	
to industrial level production. In strains engineered for chemical production, phenotypic 296	
variability manifests itself as wide distributions of metabolic production [54,20]. Such variability 297	
has been exploited to increase production by designing control that couples the concentration of 298	
product to growth, and thereby selects for high producers [68]. 299	
Mathematical modelling can provide novel insights on the sources and control of 300	
metabolic variability. For example, the integration of genome-scale models with single-cell 301	
proteomics datasets revealed the emergence of a bimodal growth distribution in E. coli [33], and 302	
the emergence of bimodal phenotypes was also explored with dynamic models [64,31]. A 303	
seminal stochastic modelling work on enzymatic reactions revealed conditions for a dynamic 304	
control circuit to amplify or attenuate the variability of a metabolic product [45]. 305	
The emergence of mutants and genotypic heterogeneity pose a significant problem for 306	
long term biochemical production, and can plague the implementation of production strains at 307	
industrial scales. Over long time scales of fermentation mutations may impair the control circuit 308	
or result in the emergence of non-producing, faster growing strains that will dilute out production 309	
strains. This is a key area for future development to help sustain long-term bioproduction in 310	
industrial settings. 311	
 312	
15	
§ 5. Final remarks 313	
Dynamic control of metabolism is a powerful mechanism for cells to survive and adapt to 314	
environmental perturbations. In natural systems, dynamic control shifts metabolic activity 315	
between various operating regimes. Metabolic engineering can harness similar control strategies 316	
to increase production in varying and often unpredictable bioreactor conditions. In this paper we 317	
outlined some of the natural strategies for dynamic control together with recent successful 318	
implementations on metabolic production pathways.  319	
Dynamic control has vast potential to enhance production at the industrial scale, enabling 320	
autonomous control of pathway activity without the cost of inducers and auto-adapting 321	
production and cellular demands according to fluctuating or changing fermentation conditions. 322	
Challenges for this technology are manifold and cover several layers of complexity, from tunable 323	
control parts, to functional circuits, accounting for host physiology and demands of the cell, and 324	
sustaining production in the face of phenotypic and emergence of genotypic heterogeneity. In 325	
this paper we discussed the challenges at these levels and how they affect the application of 326	
strains engineered with dynamic control to industrial scale bioproduction. Although a few recent 327	
studies have demonstrated the computation-guided tuning of biosensor response, the reliable 328	
determination of the intracellular metabolite concentration remains a challenge to providing 329	
accurate inputs to the model. In addition, the application of dynamic control in industrially 330	
relevant hosts has been limited, which entails tools and efforts to transfer the technology into 331	
those hosts [76]. Robust controls need to use the host resources efficiently and optimize the 332	
balance between growth and production. This is a challenging objective to achieve, and one 333	
where the metabolic engineering community can learn valuable lessons from natural systems. 334	
Systems biology has revealed fundamental design principles by reverse-engineering the 335	
regulation of natural metabolic systems, thanks to the combination of mathematical modelling 336	
16	
and wet-lab experimentation. Natural design principles and model-based methods integrated into 337	
the metabolic engineering workflow could institute the forward-engineering of control circuits 338	
and hail a new era in which dynamic control becomes the key technology for optimizing 339	
chemical production. 340	
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Figures 517	
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Figure 1. Engineered control strategies of metabolic pathway in bioproduction. To abstract 519	
the designs of different dynamic control strategies, we represent cell growth and product 520	
biosynthesis as two linear fluxes that branch from the same precursor metabolite, where growth 521	
encompasses fluxes towards essential metabolites (e.g. TCA cycle, amino acid biosynthesis, 522	
nucleotide biosynthesis, membrane biosynthesis). (a) Using inducers to control flux from the 523	
branch point [69]. (b) Using QS systems to control growth flux by negative feedback circuits 524	
[24,60]. (c) Using metabolite-responsive regulators to control toxic intermediate levels 525	
[73,18,37,70]. (d) Using growth flux to activate the production pathway [22]. (e) Using 526	
metabolite levels and growth status, which accounts for toxic effects, to regulate the production 527	
pathway [38]. (f) Using product level to control survival of the cells [68]. 528	
 529	
Figure 2. Challenges for designing dynamic control circuits at various levels. These 530	
challenges include how to tune parts to obtain desired dose-response functions, when control is 531	
actuated by riboswitches [6,52] or transcription factors [40,63]; how regulatory architectures 532	
affect dynamics [17,46,61] and robustness [43], as learned from models of natural control 533	
systems; how to balance limited resources between growth and production, studied theoretically 534	
25	
[34,67]; and how to control cell-cell heterogeneity for sustainable and efficient production, 535	
studied theoretically [45] and experimentally [68]. 536	
 537	
 538	
